ListarIOBA - Artículos de revista por tema "3209 Farmacología"

Aviso: Si va a participar en la campaña de sexenios 2024, le recomendamos que deposite en UVaDoc de forma preferente las aportaciones que vaya a presentar a dicha convocatoria (opción Autoarchivo). El resto de sus publicaciones podrá subirlas al repositorio en cualquier otro momento. Gracias.

Mostrando ítems 1-2 de 2

Potential ophthalmological application of extracts obtained from tuna vitreous humor using lactic acid-based deep eutectic systems

Abdallah, Maha M.; Leonardo, Inês C.; Krstić, Luna; Enriquez De Salamanca Aladro, Amalia ; Diebold Luque, María Yolanda ; González García, María Jesús ; Gaspar, Frédéric Bustos; Matias, Ana A.; Bronze, Maria Rosario; Fernández, Naiara (2022)
Reduction in the risk of peripheral neuropathy and lower decrease in kidney function with metformin, linagliptin or their fixed-dose combination compared to placebo in prediabetes: a randomized controlled trial

Gabriel, Rafael; Boukichou Abdelkader, Nisa; Gilis-Januszewska, Aleksandra; Makrilakis, Konstantinos; Gómez Huelgas, Ricardo; Kamenov, Zdravko; Paulweber, Bernhard; Satman, Ilhan; Djordjevic, Predrag; Alkandari, Abdullah; Mitrakou, Asimina; Lalic, Nebojsa; Egido, Jesús; Más Fontao, Sebastián; Calvet, Jean Henri; Pastor Jimeno, José Carlos ; Lindström, Jaana; Lind, Marcus; Acosta, Tania; Silva, Luis; Tuomilehto, Jaakko (2023)

ListarIOBA - Artículos de revista por tema "3209 Farmacología"

Potential ophthalmological application of extracts obtained from tuna vitreous humor using lactic acid-based deep eutectic systems ﻿

Reduction in the risk of peripheral neuropathy and lower decrease in kidney function with metformin, linagliptin or their fixed-dose combination compared to placebo in prediabetes: a randomized controlled trial ﻿

Potential ophthalmological application of extracts obtained from tuna vitreous humor using lactic acid-based deep eutectic systems

Reduction in the risk of peripheral neuropathy and lower decrease in kidney function with metformin, linagliptin or their fixed-dose combination compared to placebo in prediabetes: a randomized controlled trial